A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dean, O M; van den Buuse, M; Bush, A I; Copolov, D L; Ng, F; Dodd, S; Berk, M

Dean, O M; van den Buuse, M; Bush, A I; Copolov, D L; Ng, F; Dodd, S; Berk, M.

Affiliation

Dean OM; The Mental Health Research Institute of Victoria, Parkville, Victoria, Australia. oliviad@barwonhealth.org.au

Curr Med Chem ; 16(23): 2965-76, 2009.

Article in En | MEDLINE | ID: mdl-19689277

Subject(s)

Bipolar Disorder/etiology; Glutathione/physiology; Schizophrenia/etiology; Animals; Bipolar Disorder/drug therapy; Bipolar Disorder/metabolism; Disease Models, Animal; Free Radical Scavengers/pharmacology; Humans; Oxidative Stress; Reactive Oxygen Species/metabolism; Schizophrenia/drug therapy; Schizophrenia/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Bipolar Disorder / Glutathione Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2009 Type: Article Affiliation country: Australia

Search on Google

XML

PubMed Links